467 related articles for article (PubMed ID: 18762250)
1. ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.
Li X; Huang Y; Jiang J; Frank SJ
Cell Signal; 2008 Nov; 20(11):2145-55. PubMed ID: 18762250
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
3. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041.
Tong J; Taylor P; Peterman SM; Prakash A; Moran MF
Mol Cell Proteomics; 2009 Sep; 8(9):2131-44. PubMed ID: 19531499
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells.
Huang Y; Chang Y; Wang X; Jiang J; Frank SJ
Endocrinology; 2004 Jul; 145(7):3297-306. PubMed ID: 15070853
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF.
Saito T; Okada S; Ohshima K; Yamada E; Sato M; Uehara Y; Shimizu H; Pessin JE; Mori M
Endocrinology; 2004 Sep; 145(9):4232-43. PubMed ID: 15192046
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts.
Kim SO; Houtman JC; Jiang J; Ruppert JM; Bertics PJ; Frank SJ
J Biol Chem; 1999 Dec; 274(50):36015-24. PubMed ID: 10585492
[TBL] [Abstract][Full Text] [Related]
9. Synergy in ERK activation by cytokine receptors and tyrosine kinase growth factor receptors.
Li X; Huang Y; Jiang J; Frank SJ
Cell Signal; 2011 Feb; 23(2):417-24. PubMed ID: 20946955
[TBL] [Abstract][Full Text] [Related]
10. Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.
Yoshida T; Okamoto I; Okabe T; Iwasa T; Satoh T; Nishio K; Fukuoka M; Nakagawa K
Int J Cancer; 2008 Apr; 122(7):1530-8. PubMed ID: 18033688
[TBL] [Abstract][Full Text] [Related]
11. A role for Grb2-associated binder-1 in growth hormone signaling.
Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
[TBL] [Abstract][Full Text] [Related]
12. Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.
Justman QA; Clinton GM
J Biol Chem; 2002 Jun; 277(23):20618-24. PubMed ID: 11934884
[TBL] [Abstract][Full Text] [Related]
13. Role of threonine residues in regulation of the epidermal growth factor receptor by protein kinase C and mitogen-activated protein kinase.
Morrison P; Takishima K; Rosner MR
J Biol Chem; 1993 Jul; 268(21):15536-43. PubMed ID: 8393447
[TBL] [Abstract][Full Text] [Related]
14. Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function.
Xu D; Makkinje A; Kyriakis JM
J Biol Chem; 2005 Jan; 280(4):2924-33. PubMed ID: 15556944
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.
Deb TB; Su L; Wong L; Bonvini E; Wells A; David M; Johnson GR
J Biol Chem; 2001 May; 276(18):15554-60. PubMed ID: 11279155
[TBL] [Abstract][Full Text] [Related]
16. Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites.
Decker SJ
J Biol Chem; 1993 May; 268(13):9176-9. PubMed ID: 8387484
[TBL] [Abstract][Full Text] [Related]
17. The linoleic acid metabolite, (13S)-hydroperoxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. Differential response in Syrian hamster embryo tumor suppressor phenotypes.
Glasgow WC; Hui R; Everhart AL; Jayawickreme SP; Angerman-Stewart J; Han BB; Eling TE
J Biol Chem; 1997 Aug; 272(31):19269-76. PubMed ID: 9235921
[TBL] [Abstract][Full Text] [Related]
18. A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2).
Hartman Z; Geldenhuys WJ; Agazie YM
J Biol Chem; 2020 Mar; 295(11):3563-3575. PubMed ID: 32024694
[TBL] [Abstract][Full Text] [Related]
19. Role of mitogen-activated protein kinase kinase in regulation of the epidermal growth factor receptor by protein kinase C.
Morrison P; Saltiel AR; Rosner MR
J Biol Chem; 1996 May; 271(22):12891-6. PubMed ID: 8662819
[TBL] [Abstract][Full Text] [Related]
20. Epidermal Growth Factor Induces Proliferation of Hair Follicle-Derived Mesenchymal Stem Cells Through Epidermal Growth Factor Receptor-Mediated Activation of ERK and AKT Signaling Pathways Associated with Upregulation of Cyclin D1 and Downregulation of p16.
Bai T; Liu F; Zou F; Zhao G; Jiang Y; Liu L; Shi J; Hao D; Zhang Q; Zheng T; Zhang Y; Liu M; Li S; Qi L; Liu JY
Stem Cells Dev; 2017 Jan; 26(2):113-122. PubMed ID: 27702388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]